Of note, we found that cetuximab reacted with TAF (identified by vimentin staining, Figures 4D,I,P) at the tumor site in CRC (Figure 4B, enlarged in Figure 4C) and stained also FB in non-neoplastic areas (Figure 4G, enlarged in Figure 4H). Here, VIM is linked to colorectal carcinoma.